Browse by Phase
Phase 2 Clinical Trials
Phase 2 trials study whether a drug works in people with a specific disease or condition. These studies enroll 100–300 participants and also continue to evaluate safety.
Total Trials
1,071
Recruiting Now
1,071
Top Conditions in Phase 2
NCT03339128 Phase 2
Recruiting
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bow...
Condition
Irritable Bowel Syndrome
Enrollment
95 pts
Location
United States, Bulgaria, Canada
Sponsor
AbbVie
NCT06114628 Phase 2
Recruiting
Platform Assessing Regimens and Durations In a Global Multisite Consortium for T...
Condition
Pulmonary Tuberculosis
Enrollment
2,500 pts
Location
Moldova, South Africa, Tanzania
Sponsor
University College, London
NCT06739928 Phase 2
Recruiting
Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin ...
Condition
Small Cell Lung Cancer Extensive Stage
Enrollment
120 pts
Location
China
Sponsor
Guangzhou Institute of Respira
NCT07074665 Phase 2
Recruiting
Dose Finding Trial of R21/Matrix-M in School Children
Condition
Malaria (Plasmodium Falciparum)
Enrollment
40 pts
Location
Burkina Faso
Sponsor
University of Oxford
NCT06802666 Phase 2
Recruiting
Short-course Radiotherapy Followed by AK112 and CAPOX as Neoadjuvant Therapy for...
Condition
Locally Advanced Rectal Cancer
Enrollment
45 pts
Location
China
Sponsor
Union Hospital, Tongji Medical
NCT07077902 Phase 2
Recruiting
A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hid...
Condition
Hidradenitis Suppurativa
Enrollment
10 pts
Location
United States
Sponsor
Tulane University
NCT07052253 Phase 2
Recruiting
A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for...
Condition
Hepatocellular Carcinoma (HCC)
Enrollment
100 pts
Location
China
Sponsor
Akeso
NCT06743945 Phase 2
Recruiting
POLA-R-CHP in the First-line Treatment of Transformed DLBCL
Condition
Transformed Lymphoma
Enrollment
20 pts
Location
China
Sponsor
Fudan University
NCT06826872 Phase 2
Recruiting
Efficacy and Safety of SPC1001 in Patients With Essential Hypertension
Condition
Hypertension, Essential
Enrollment
252 pts
Location
South Korea
Sponsor
Shin Poong Pharmaceutical Co.
NCT03767075 Phase 2
Recruiting
A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients...
Condition
Advanced Solid Tumor
Enrollment
1,000 pts
Location
France, Germany, Italy
Sponsor
Vall d'Hebron Institute of Onc
NCT07321301 Phase 2
Recruiting
Polymer-lipid Particle-delivered CAR1920 mRNA CAR-T Therapy for Relapsed/Refract...
Condition
B-cell Lymphoma Refractory
Enrollment
10 pts
Location
China
Sponsor
Daihong Liu
NCT07058519 Phase 2
Recruiting
A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitorin...
Condition
Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC)
Enrollment
250 pts
Location
China
Sponsor
Shanghai Chest Hospital
NCT02407028 Phase 2
Recruiting
Hyperbaric Oxygen Brain Injury Treatment Trial
Condition
Traumatic Brain Injury
Enrollment
200 pts
Location
United States, Canada
Sponsor
Gaylan Rockswold
NCT07027111 Phase 2
Recruiting
Safety, Tolerability, and Efficacy of NVG-2089 in Participants With CIDP
Condition
Chronic Inflammatory Demyelinating Polyneuropathy
Enrollment
60 pts
Location
United States
Sponsor
Nuvig Therapeutics, Inc.
NCT05782244 Phase 2
Recruiting
Sildenafil for Microvasculopathy in Chronic TBI
Condition
Traumatic Brain Injury
Enrollment
160 pts
Location
United States
Sponsor
University of Pennsylvania
NCT07431853 Phase 2
Recruiting
A Study to Learn About mRNA Vaccines Against Influenza in Adults
Condition
Healthy Adults
Enrollment
770 pts
Location
United States
Sponsor
Pfizer
NCT06845553 Phase 2
Recruiting
A Study to Assess the Efficacy and Safety of Vutiglabridin in Knee Osteoarthriti...
Condition
Knee Osteoarthritis (Knee OA)
Enrollment
60 pts
Location
South Korea
Sponsor
Glaceum
NCT04984837 Phase 2
Recruiting
Study of Lacutamab in Peripheral T-cell Lymphoma
Condition
Peripheral T Cell Lymphoma
Enrollment
56 pts
Location
Belgium, France, Germany
Sponsor
The Lymphoma Academic Research
NCT06580145 Phase 2
Recruiting
Leucine in Midlife Depression
Condition
Major Depression
Enrollment
75 pts
Location
United States
Sponsor
Emory University
NCT06792695 Phase 2
Recruiting
A Study of Novel Study Interventions and Combinations in Participants With Color...
Condition
Metastatic Colorectal Cancer
Enrollment
120 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
NCT06675357 Phase 2
Recruiting
Using FAPI PET/MRI to Evaluate Prostate Cancer
Condition
Prostate Cancer Metastatic Disease
Enrollment
30 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT04888481 Phase 2
Recruiting
68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors
Condition
Neuroendocrine Tumors
Enrollment
600 pts
Location
Canada
Sponsor
University of Alberta
NCT06266611 Phase 2
Recruiting
Cannabis for Palliative Care in Cancer
Condition
Sleep
Enrollment
185 pts
Location
United States
Sponsor
University of Colorado, Boulde
NCT06808971 Phase 2
Recruiting
Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Peri...
Condition
Gastric Adenocarcinoma
Enrollment
61 pts
Location
China
Sponsor
Cancer Institute and Hospital,
NCT05926271 Phase 2
Recruiting
POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy
Condition
Acute Coronary Syndrome
Enrollment
200 pts
Location
Netherlands
Sponsor
St. Antonius Hospital